Gainers
- Unicycive Therapeutics UNCY stock rose 25.3% to $0.81 during Friday's regular session. The current volume of 64.4K shares is 208.0% of Unicycive Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $12.1 million.
- TransMedics Group TMDX stock moved upwards by 22.59% to $55.33. Trading volume for TransMedics Group's stock is 1.2 million as of 13:30 EST. This is 277.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion. The company's, Q3 earnings came out yesterday.
- Macrogenics MGNX shares moved upwards by 22.52% to $5.93. The current volume of 1.0 million shares is 128.4% of Macrogenics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $364.4 million. The company's, Q3 earnings came out yesterday.
- Insulet PODD shares rose 17.62% to $300.35. Trading volume for Insulet's stock is 1.2 million as of 13:30 EST. This is 315.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.8 billion. As per the news, the Q3 earnings report came out yesterday.
- Vir Biotechnology VIR stock rose 16.65% to $25.43. Trading volume for Vir Biotechnology's stock is 1.0 million as of 13:30 EST. This is 101.7% of its average full-day volume over the last 100 days. The company's market cap stands at $3.3 billion. As per the news, the Q3 earnings report came out yesterday.
- Puma Biotechnology PBYI shares rose 15.65% to $2.48. The current volume of 328.0K shares is 180.0% of Puma Biotechnology's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $112.7 million. As per the press release, Q3 earnings came out yesterday.
Losers
- Pulmonx LUNG stock decreased by 66.7% to $4.11 during Friday's regular session. Trading volume for this security as of 13:30 EST is 3.4 million, which is 1075.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $153.1 million. As per the news, the Q3 earnings report came out yesterday.
- Syneos Health SYNH shares fell 47.54% to $25.09. As of 13:30 EST, this security is trading at a volume of 4.8 million shares, making up 633.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
- Sensus Healthcare SRTS stock declined by 45.16% to $7.13. As of 13:30 EST, this security is trading at a volume of 2.2 million shares, making up 572.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.0 million. As per the press release, Q3 earnings came out yesterday.
- NeuroBo Pharmaceuticals NRBO shares fell 43.15% to $2.65. The current volume of 979.6K shares is 165.3% of NeuroBo Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $2.3 million.
- DermTech DMTK shares declined by 42.0% to $1.74. As of 13:30 EST, this security is trading at a volume of 2.2 million shares, making up 490.4% of its average full-day volume over the last 100 days. The company's market cap stands at $52.2 million. As per the press release, Q3 earnings came out yesterday.
- Vapotherm VAPO stock fell 37.31% to $0.79. Vapotherm's stock is trading at a volume of 615.3K shares as of 13:30 EST. This is 358.1% of its average full-day volume over the last 100 days. The company's market cap stands at $21.0 million. As per the press release, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in